Company / Operating Income
Omnicell Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$5.2M
FY2025
5-year range
-$34.9M / $78.4M
FY2021-FY2025
Trend
+1431.2%
vs FY2024
Sector context
#103 of 156
Health Care
What the data says
Operating Income changed +1431% YoY in FY2025, a notable deviation from the 9-year average annual change of +200%.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -35.0%.
Improved from -$35M to $5M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -47.4%
- 5-Year CAGR
- -35.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 156 in Health CareTop 66% of 156This company $5.2M Sector average $733.1M
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -35.0%, indicating a declining trend.
- In FY2025, operating income increased 1431.2% year-over-year.
- Ranks #103 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2M | +1431.2% |
| FY2024 | $337.0K | +101.0% |
| FY2023 | -$34.9M | -198.1% |
| FY2022 | $35.5M | -54.7% |
| FY2021 | $78.4M | +76.5% |
| FY2020 | $44.4M | +298.3% |
| FY2019 | $11.1M | -74.9% |
| FY2018 | $44.4M | +298.3% |
| FY2017 | $11.1M | -77.5% |
| FY2016 | $49.6M | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026